Find a medicine Medicines Veterinary Medicines Generics Advanced Search I want to: Report an issue Get fees info See guides & forms Visit the Innovation Office Latest updates All updates Safety notices Publications & Forms About Us Publications & Forms Forms & Applications 22.06.2018 Expedited assessment application for variation to Annex 3 or 4 of an IMP authorisation v1 Publications & Forms About Us Publications & Forms Guidance Documents 21.06.2018 Guide to Clinical Trial Applications News & Events Medicines News & Events News 12.06.2018 Public consultation: HPRA invites comments on draft framework for multi-stakeholder approach to handling medicines shortages News & Events Medical Devices Medical Devices News & Events News 12.06.2018 HPRA public consultation on medical devices fees for 2018: Response document Publications & Forms 12.06.2018 Outcome of the Process - Public Consultation on proposed Medical Device fees for 2018 Recruitment Medicines 11.06.2018 Pharmaceutical Assessor, Pharmaceutical Assessment – Human Products Authorisation and Registration Safety Notices Cosmetics Safety Information Safety Notices Advisory 07.06.2018 Cosmetic Products Safety Notices - Updated 7 June 2018 View all updates » Safety Notices Cosmetics Safety Information Safety Notices Advisory 07.06.2018 Cosmetic Products Safety Notices - Updated 7 June 2018 Safety Notices Medical Devices Safety Information Safety Notices Warning 06.06.2018 Covidien Endo GIA™ Articulating Reloads. Priority 2 – Warning Safety Notices Medicines Safety Notices 3rd Party Publications 06.06.2018 Vectibix (panitumumab) - Important Safety Information from Amgen as approved by the HPRA Safety Notices Medicines Safety Notices 3rd Party Publications 05.06.2018 Summary of Direct Healthcare Professional Communications (DHPCs) issued in May 2018 Safety Notices Medical Devices Safety Information Safety Notices 3rd Party Publications 01.06.2018 Summary of Field Safety Notices - May 2018 Safety Notices Medical Devices Safety Information Safety Notices For Immediate Action 29.05.2018 Aquilon series of nebulisers - Priority 1 - For Immediate Action Safety Notices Medicines Safety Notices 3rd Party Publications 28.05.2018 Granulocyte colony-stimulating factors (G-CSFs) (Filgrastim, Lenograstim, Lipegfilgrastim and Pegfilgrastim) - Important Safety Information from Amgen Europe B.V, Chugai Pharma UK, Teva, Apotex Europe B.V, and Accord Healthcare Ltd as approved by the HPRA View all updates » The HPRA for: Patients & Public Healthcare Professionals Industry Innovation Office Brexit Educational Material Emergency Medicines Portal Publications and Forms Newsletters Report Suspicious Activities Vaccines Generic & Interchangeable Medicines